Filing Details

Accession Number:
0001213900-25-046087
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-20 18:03:12
Reporting Period:
2025-05-16
Filing Date:
2025-05-20
Accepted Time:
2025-05-20 18:03:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1553643 Relmada Therapeutics Inc. RLMD Pharmaceutical Preparations (2834) 455401931
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1658369 Maged Shenouda C/O Relmada Therapeutics, Inc.
2222 Ponce De Leon Blvd, 3Rd Floor
Coral Gables FL 33134
Chief Financial Officer No Yes No No
Transaction Summary
Purchased: 200,000 shares Avg. Price: $0.49 Total Value: $97,208.00
Number of Shares After Transactions: 288,335 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-05-16 50,000 $0.44 138,335 No 4 P Direct
Common Stock Acquisiton 2025-05-19 90,000 $0.49 228,335 No 4 P Direct
Common Stock Acquisiton 2025-05-20 60,000 $0.52 288,335 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
  2. Purchase prices range from $0.4229 to $0.4674 per share, inclusive.
  3. Purchase prices range from $0.4493 to $0.4998 per share, inclusive.
  4. Purchase prices range from $0.4998 to $0.5396 per share, inclusive.